Lu, Hongxia <br/><br/>
Paclitaxel nanoparticle inhibits growth of ovarian cancer xenografts and enhances lymphatic targeting.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  Feb 2007 
 - 175-81 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0344-5704 
<br/><br/><label>Standard No.: </label>10.1007/s00280-006-0256-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents, Phytogenic--administration & dosage<br/>Apoptosis--drug effects<br/>Ascites--drug therapy<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Drug Delivery Systems--methods<br/>Female<br/>Gene Expression Regulation--drug effects<br/>In Situ Nick-End Labeling<br/>Lymph Nodes--drug effects<br/>Lymphatic Vessels--drug effects<br/>Matrix Metalloproteinase 1--genetics<br/>Matrix Metalloproteinase 9--genetics<br/>Matrix Metalloproteinase Inhibitors<br/>Nanoparticles--administration & dosage<br/>Ovarian Neoplasms--drug therapy<br/>Paclitaxel--administration & dosage<br/>Proliferating Cell Nuclear Antigen--metabolism<br/>RNA, Messenger--genetics<br/>Rats<br/>Rats, Inbred F344<br/>Reverse Transcriptase Polymerase Chain Reaction--methods<br/>Xenograft Model Antitumor Assays